GlassScriptPhysician profile
James Cooper Brien
NPI 1538383658
$3,859.10
in general payments reported to CMS, 2019-2025
37 companies · $497 in 2025
The $497 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $476 · 2021: $221 · 2022: $1,064 · 2023: $574 · 2024: $481 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548 · Education: $4.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,547.56 |
| Education | $4.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $608.79 | 2019-2025 | Lupron Depot |
| Janssen Biotech, INC. | $532.70 | 2019-2025 | Erleada |
| Neotract INC. | $271.91 | 2019-2020 | |
| Astellas Pharma US INC | $257.66 | 2019-2025 | Xtandi |
| Pfizer INC. | $244.51 | 2019-2023 | |
| Urogen Pharma, INC. | $237.01 | 2022-2024 | Jelmyto |
| Medtronic, INC. | $233.68 | 2022-2025 | Interstim |
| Boston Scientific Corporation | $211.64 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Bayer Healthcare Pharmaceuticals INC. | $162.65 | 2023-2025 | |
| Tolmar Pharmaceuticals, INC. | $135.59 | 2022 | |
| Endo USA, INC. | $98.05 | 2024-2025 | Xiaflex |
| Merck Sharp & Dohme LLC | $74.98 | 2020-2024 | Keytruda |
| Sumitomo Pharma America, INC. | $68.62 | 2023-2025 | Orgovyx |
| Coloplast Corp | $67.76 | 2022-2024 | |
| Olympus America INC. | $64.44 | 2023-2024 | Itind System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $48.74 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $44.75 | 2022-2023 | Opdivo |
| Endo Pharmaceuticals INC. | $43.25 | 2019-2023 | Aveed, Xiaflex |
| Dendreon Pharmaceuticals LLC | $42.07 | 2023-2024 | Provenge |
| Amgen INC. | $41.08 | 2019 | |
| Antares Pharma, INC. | $40.84 | 2020-2022 | |
| Progenics Pharmaceuticals, INC. | $36.76 | 2024-2025 | |
| Srs Medical Systems, INC. | $29.27 | 2022 | |
| Medtronic USA, INC. | $28.64 | 2020 | |
| Axonics, INC. | $24.47 | 2023 | Axonics |
| Smith+Nephew, INC. | $23.83 | 2025 | Stravix |
| Bioprotect Medical, INC. | $23.20 | 2025 | Bioprotect Balloon Implant System |
| Procept Biorobotics Corporation | $22.24 | 2025 | |
| Photocure INC | $20.51 | 2024 | Cysview |
| Ferring Pharmaceuticals INC. | $17.24 | 2025 | Adstiladrin |
| Calyxo, INC. | $17.02 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $16.97 | 2020 | |
| Angiodynamics, INC. | $16.66 | 2025 | Nanoknife |
| Ambu INC. | $16.53 | 2020 | |
| Palette Life Sciences, INC. | $15.58 | 2023 | |
| Laborie Medical Technologies Corp. | $15.34 | 2025 | |
| Travere Therapeutics, INC. | $4.12 | 2023-2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.